Overview A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 Status: Completed Trial end date: 2014-11-30 Target enrollment: Participant gender: Summary The purpose of this study is to see how ALS-008176 is taken up, broken down, and removed from the body. Phase: Phase 1 Details Lead Sponsor: Alios Biopharma Inc.